Moomoo AIのまとめ
On March 20, 2024, RA Capital Management, L.P., along with individuals Peter Kolchinsky and Rajeev Shah, and RA Capital Healthcare Fund, L.P., collectively filed a Schedule 13G with the United States Securities and Exchange Commission (SEC) regarding their ownership in Sera Prognostics, Inc. The filing indicates that these entities and individuals collectively hold 2,047,221 shares of Sera Prognostics' Class A Common Stock, representing 6.5% of the class. RA Capital Management serves as the investment adviser to the RA Capital Healthcare Fund and may be deemed a beneficial owner of the securities held by the fund. The shares are reported based on the total number of Class A Common Stock outstanding as of March 15, 2024, as stated in Sera Prognostics' Annual Report on Form 10-K. The filing also includes a disclaimer by the reporting persons, stating that they do not claim beneficial ownership of the reported securities for any purpose other than to determine their obligations under Section 13(d) of the Securities Exchange Act of 1934.
On March 20, 2024, RA Capital Management, L.P., along with individuals Peter Kolchinsky and Rajeev Shah, and RA Capital Healthcare Fund, L.P., collectively filed a Schedule 13G with the United States Securities and Exchange Commission (SEC) regarding their ownership in Sera Prognostics, Inc. The filing indicates that these entities and individuals collectively hold 2,047,221 shares of Sera Prognostics' Class A Common Stock, representing 6.5% of the class. RA Capital Management serves as the investment adviser to the RA Capital Healthcare Fund and may be deemed a beneficial owner of the securities held by the fund. The shares are reported based on the total number of Class A Common Stock outstanding as of March 15, 2024, as stated in Sera Prognostics' Annual Report on Form 10-K. The filing also includes a disclaimer by the reporting persons, stating that they do not claim beneficial ownership of the reported securities for any purpose other than to determine their obligations under Section 13(d) of the Securities Exchange Act of 1934.
2024年3月20日、RA Capital Management、L.P.、Peter Kolchinsky氏、Rajeev Shah氏、およびRA Capital Healthcare Fund、L.P.は、Sera Prognostics、Inc.の所有に関する米国証券取引委員会（SEC）に対してSchedule 13Gを提出しました。ファイリングによれば、これらの法人および個人は、Sera Prognosticsの普通株式クラスAの中で2,047,221株を保有しており、当該クラスの6.5％を占めています。 RA Capital Managementは、RA Capital Health...すべて展開
2024年3月20日、RA Capital Management、L.P.、Peter Kolchinsky氏、Rajeev Shah氏、およびRA Capital Healthcare Fund、L.P.は、Sera Prognostics、Inc.の所有に関する米国証券取引委員会（SEC）に対してSchedule 13Gを提出しました。ファイリングによれば、これらの法人および個人は、Sera Prognosticsの普通株式クラスAの中で2,047,221株を保有しており、当該クラスの6.5％を占めています。 RA Capital Managementは、RA Capital Healthcare Fundの投資顧問として、基金が保有する証券の有益所有者と見なされる可能性があります。保有する株式は、Sera Prognosticsの10-Kフォームに記載されている2024年3月15日現在の発行済み普通株式クラスAの総数に基づいて報告されています。ファイリングには、報告者による免責事項も含まれており、報告された証券の有益所有権を、証券取引法第13(d)条に基づき義務を決定するため以外の目的で主張しないことを述べています。
役に立った
役に立たない